{"schema_version":"1","generated_at":"2026-11-11T20:05:12.288Z","data_as_of":null,"url":"https://www.findmykol.com/kol/anthony-costales","json_url":"https://www.findmykol.com/kol/anthony-costales/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"anthony-costales","name":"Anthony Costales","credential":"MD","specialty":"Gynecologic Oncology","specialty_raw":"Gynecologic Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Baylor College of Medicine","institution_url":"https://www.findmykol.com/institution/baylor-college-of-medicine","city":"Houston","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1578828703","orcid":"0000-0003-4326-9782","openalex":"A5012410782"},"summary":"Anthony Costales is an Oncology physician affiliated with Baylor College of Medicine. OpenAlex indexes 61 publications with 383 citations (h-index 11); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":61,"cited_by_count":383,"h_index":11,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04586959","title":"Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer","phase":"NA","status":"RECRUITING","role":"Overall official","sponsor":"Anthony Costales, MD","source_url":"https://clinicaltrials.gov/study/NCT04586959","trial_url":"https://www.findmykol.com/trial/NCT04586959"}],"source":"trials"},"payments":{"company_count":13,"program_years":{"first":2021,"last":null},"rows_total":21,"shown":3,"withheld":18,"rows":[{"payer":"On Target Laboratories, Inc","program_year":2025,"amount_usd":118.8,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1578828703"},{"payer":"Daiichi Sankyo Inc.","program_year":2025,"amount_usd":54.69,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1578828703"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":43.25,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1578828703"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1578828703","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Blood & clotting","share_pct":25.6,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":25.6,"drugs":[{"name":"Eliquis","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":25.6,"classes_total":1,"classes":[{"class":"Nonsteroidal Anti-inflammatory Drug","setting":"prescribed","share_pct":25.6,"drugs":[{"name":"Ibuprofen","share_pct":100}],"max_beneficiaries":20}]},{"area":"Respiratory","share_pct":25.6,"classes_total":1,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":25.6,"drugs":[{"name":"Hydrocodone-Acetaminophen","share_pct":100}],"max_beneficiaries":17}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Chemoradiation after chemotherapy for metastatic cervical cancer can provide chemo-free time","year":2026,"journal":"Frontiers in Oncology","source_url":"https://doi.org/10.3389/fonc.2026.1826017","status":"verified"},{"title":"Real-world experience with INTERLACE-style induction chemotherapy: Tumor regression and MRI-guided brachytherapy in locally advanced cervical cancer","year":2026,"journal":"Gynecologic Oncology Reports","source_url":"https://doi.org/10.1016/j.gore.2026.102231","status":"verified"},{"title":"Racial and ethnic disparities in mucinous ovarian cancer: A National Cancer Database study","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.01.429","status":"verified"},{"title":"Phase I study of niraparib with radiotherapy for treatment of metastatic and locally advanced invasive carcinoma of the cervix (NIVIX)","year":2026,"journal":"Frontiers in Oncology","source_url":"https://doi.org/10.3389/fonc.2026.1677424","status":"verified"},{"title":"Chemoradiation following chemotherapy for metastatic cervical cancer","year":2025,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2025.04.294","status":"verified"}],"source":"works"},"contact":{"address_1":"1919 OLD SPANISH TRL FL 7","city":"Houston","state":"TX","zip":"770542003","phone":"713-798-1999","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1578828703","source":"identity"},"similar":[{"name":"Christie Ballantyne","slug":"christie-ballantyne","institution":"Baylor College of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/christie-ballantyne","json_url":"https://www.findmykol.com/kol/christie-ballantyne/profile.json"},{"name":"Biykem Bozkurt","slug":"biykem-bozkurt","institution":"Baylor College of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/biykem-bozkurt","json_url":"https://www.findmykol.com/kol/biykem-bozkurt/profile.json"},{"name":"Malcolm Brenner","slug":"malcolm-brenner","institution":"Baylor College of Medicine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/malcolm-brenner","json_url":"https://www.findmykol.com/kol/malcolm-brenner/profile.json"},{"name":"Sankar Navaneethan","slug":"sankar-navaneethan","institution":"Baylor College of Medicine","specialty":"Nephrology","url":"https://www.findmykol.com/kol/sankar-navaneethan","json_url":"https://www.findmykol.com/kol/sankar-navaneethan/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":18,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-07-01","provider_certified":"2024-07-01","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}